LifeNet Health

VP, Global Regulatory and Clinical Affairs

About

Alyce received her BS in Biology with a minor in Chemistry, MS with an emphasis in Immunology, and Ph.D. in Biomedical Sciences with an emphasis in tissue engineering and cell biology from Old Dominion University in Norfolk, Virginia.  She has been performing research for LifeNet Health since 1996, has been employed by LifeNet Health since 2001, and currently holds the title of VP, Global Regulatory and Clinical Affairs. She is responsible for global regulatory compliance, submissions, clinical trials, and risk management.  Before this role, she was Director, Cardiovascular Research and Product Development, overseeing decellularized cardiovascular allograft development and market launch. During her career, the use of standards has played an integral role in successfully bringing new products to market and successfully obtaining market authorizations globally.  Alyce has been an active member of ASTM since 2001, chairing F2529-13, “Standard Guide for In Vivo Evaluation of Osteoinductive Potential for Materials Containing Demineralized Bone.” She has also served on multiple ASTM workgroups developing new standards for Tissue Engineered Medical Products, TEMPS, over various disciplines such as cardiovascular, cell biology, microbiological, osteobiologic, and skin substitutes.  Alyce is also a member of the American Association of Tissue Banks Scientific and Technical Affairs Committee, previous Chair of the AATB Ethics and Bylaws Committee, a co-author of the AATB Microbial Surveillance Guidance Document, and a member of Tissue Policy Group. She has various publications and book chapters in the field of cardiovascular tissue engineering and processing and well as multiple patents.